The rate of MS was particularly reduced… Sudo Biosciences has raised $116 million in a Series B financing to support the clinical development of two inhibitors of the TYK2 enzyme for treating ...

Welcome to the Department of Biosciences. The department delivers innovative, TEF Gold standard teaching and research in subjects including biomedical science, microbiology, biochemistry, pharmacology ...

Harmony Biosciences Holdings, Inc.'s Wakix, a first-in-class drug for narcolepsy, has shown strong revenue growth and recent label expansion to pediatric patients, with good future growth potential.

OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources ...

Dis­ease-re­ver­sal start­up Retro Bio­sciences is aim­ing for a $1 bil­lion fund­ing round, a spokesper­son for the com­pa­ny con­firmed in a Fri­day email to End­points News … ...

Colossal Biosciences CEO and co-founder Ben Lamm gets the Jurassic Park comparison. When your company is trying to bring back the woolly mammoth, it’s only natural that people compare it to the ...

If you have users that need certain admin privileges on your Linux machines, here's a walk-through of the process for granting full or specific rights. How many times have you created a new user ...

The Biotech Beach Hotbed includes San Diego, Los Angeles and the surrounding (Torrey Pines, Thousand Oaks) regions of Southern California. SoCal is well-known for its sprawling beaches and ...

OpenAI teamed up with Retro Biosciences to build a machine learning model focused on generating new proteins. The new model, called GPT-4b, is a custom version of OpenAI’s GPT-4o model built ...

Whitecap Biosciences’ investigational medicines show real promise when it comes to slowing vision loss and perhaps even improving vision for patients with glaucoma, which would be a long-overdue ...